If A-SAA is a direct mediator of obesity-associated inflammation and its metabolic and cardiovascular consequences, might serum A-SAA be a better indicator of obesity-associated CVD risk than CRP? The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.